• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932

Introduction to 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide (CAS No. 1353959-57-5)

2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and biochemistry due to its unique structural properties and potential applications. This compound, identified by its Chemical Abstracts Service (CAS) number CAS No. 1353959-57-5, belongs to a class of molecules that exhibit promising biological activity. The detailed analysis of its chemical structure and functional groups provides valuable insights into its potential roles in drug development and therapeutic interventions.

The molecular formula of 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide can be represented as C₁₂H₁₈N₂OCl. This composition includes a chloro substituent, an n-ethyl group, and a 1-methyl-piperidin-4-yl moiety, which are critical for its interactions with biological targets. The presence of these functional groups suggests that the compound may possess the ability to modulate various biological pathways, making it a candidate for further investigation in medicinal chemistry.

In recent years, there has been a growing interest in the development of novel compounds that can interact with specific enzymes or receptors in the human body. The n-(1-methyl-piperidin-4-yl) group in the compound's structure is particularly noteworthy, as piperidine derivatives are known for their role in enhancing the bioavailability and pharmacological activity of many pharmaceutical agents. This feature makes 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide a promising candidate for further exploration in the design of new drugs.

The synthesis of 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide involves a series of well-defined chemical reactions that require precise control over reaction conditions and reagent selection. The chloro substituent at the second carbon position introduces a level of reactivity that can be exploited for further functionalization, allowing chemists to tailor the compound's properties for specific applications. Advanced synthetic methodologies, such as nucleophilic substitution reactions and condensation processes, are typically employed to construct this complex molecule.

The pharmacological potential of 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide has been explored in several preclinical studies. These investigations have highlighted its ability to interact with various biological targets, including enzymes and receptors involved in pain signaling, inflammation, and neurotransmission. The compound's structural features suggest that it may have therapeutic effects similar to those of existing drugs used in the treatment of chronic pain and neurological disorders. However, further research is needed to fully elucidate its mechanism of action and to determine its safety and efficacy profile.

In addition to its potential therapeutic applications, 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide has also been studied for its role in chemical biology research. Its unique structure provides a valuable tool for investigating the function of target proteins and for developing new methods to modulate biological pathways. By using this compound as a probe molecule, researchers can gain insights into the complex interactions that occur within cells and how these interactions contribute to disease processes.

The latest advancements in computational chemistry have also contributed to our understanding of 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide. Molecular modeling techniques allow scientists to predict how this compound will interact with biological targets at the atomic level. These predictions can guide the design of new derivatives with enhanced pharmacological properties and can help identify potential side effects before costly experimental trials are conducted. The integration of computational methods with traditional experimental approaches has significantly accelerated the drug discovery process.

The industrial production of 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide is another area where innovation has been ongoing. Manufacturers are continuously improving synthetic routes to increase yield, reduce costs, and minimize environmental impact. Green chemistry principles are being applied to develop more sustainable production methods that align with global efforts to reduce waste and energy consumption. These advancements ensure that the compound can be produced efficiently while adhering to stringent regulatory standards.

The regulatory landscape for pharmaceutical compounds like 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-yl)-acetamide is complex and requires careful navigation by researchers and manufacturers. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines on drug development to ensure safety and efficacy. Compliance with these regulations is essential for any compound intended for human use, and researchers must demonstrate thorough understanding of both chemical synthesis and pharmacological principles.

In conclusion, 2-Chloro-n-ethyl-n-(1-methyl-piperidin-4-y acetamide (CAS No. 1353959- 57- 5) represents a significant advancement in pharmaceutical chemistry with potential applications across multiple therapeutic areas. Its unique structural features make it a valuable tool for both research and drug development purposes. As our understanding of biological systems continues to grow, compounds like this one will play an increasingly important role in addressing complex diseases and improving patient outcomes.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)